Investigating the cell permeability of proteolysis-targeting chimeras (PROTACs)

被引:13
|
作者
Yokoo, Hidetomo [1 ,2 ]
Naito, Mikihiko [1 ,3 ,6 ]
Demizu, Yosuke [1 ,4 ,5 ,7 ]
机构
[1] Natl Inst Hlth Sci, Div Organ Chem, Kawasaki, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Med Chem, Kyoto, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo, Japan
[4] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Japan
[5] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Kita, Japan
[6] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Targeted Prot Degradat, Tokyo 1130033, Japan
[7] Natl Inst Hlth Sci, Div Organ Chem, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan
基金
日本学术振兴会;
关键词
Cell permeability; cell-penetrating peptide; molecular weight; nanoparticle; prodrug; PROTAC; SOLUBILITY; MOLECULES; DESIGN;
D O I
10.1080/17460441.2023.2187047
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:357 / 361
页数:5
相关论文
共 50 条
  • [1] Proteolysis-targeting chimeras (PROTACs) in cancer therapy
    Xinyi Li
    Wenchen Pu
    Qingquan Zheng
    Min Ai
    Song Chen
    Yong Peng
    Molecular Cancer, 21
  • [2] Proteolysis-targeting chimeras (PROTACs) in cancer therapy
    Li, Xinyi
    Pu, Wenchen
    Zheng, Qingquan
    Ai, Min
    Chen, Song
    Peng, Yong
    MOLECULAR CANCER, 2022, 21 (01)
  • [3] PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
    Vicente, Andre T. S.
    Salvador, Jorge A. R.
    MEDCOMM, 2024, 5 (06):
  • [4] Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
    Li, Rui
    Liu, Miao
    Yang, Zhenya
    Li, Jiao
    Gao, Yuxin
    Tan, Ruirong
    MOLECULES, 2022, 27 (24):
  • [5] PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras
    Jyotsana Madan
    Vijay Kamal Ahuja
    Kamal Dua
    Susanta Samajdar
    Murali Ramchandra
    Sanjeev Giri
    BioDrugs, 2022, 36 : 609 - 623
  • [6] PROTACs: Current Trends in Protein Degradation by Proteolysis-Targeting Chimeras
    Madan, Jyotsana
    Ahuja, Vijay Kamal
    Dua, Kamal
    Samajdar, Susanta
    Ramchandra, Murali
    Giri, Sanjeev
    BIODRUGS, 2022, 36 (05) : 609 - 623
  • [7] Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
    Tamatam, Rekha
    Shin, Dongyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [8] Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
    Fan, Lianlian
    Tong, Weifang
    Wei, Anhui
    Mu, Xupeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 275
  • [9] Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4
    Cai, Maohua
    Ma, Furong
    Hu, Can
    Li, Haobin
    Cao, Fei
    Li, Yulong
    Dong, Jinyun
    Qin, Jiang-Jiang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 90
  • [10] Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
    Moon, Yujeong
    Jeon, Seong Ik
    Shim, Man Kyu
    Kim, Kwangmeyung
    PHARMACEUTICS, 2023, 15 (02)